BROMO EMPAGLIFLOZIN
UNII 5DM2VC3NJM

Substance Identification & Data

This profile provides standardized clinical and technical data for Bromo Empagliflozin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 5DM2VC3NJM.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3123196-95-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
5DM2VC3NJM
CAS Registry Number
3123196-95-9
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
BROMO EMPAGLIFLOZIN
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C23H27BrO7
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
WETJYJMFYZMTCR-QZMOQZSNSA-N
Line notation for describing the chemical structure and connectivity of atoms.
PubChem CID
Unique identification number in the NCBI database of chemical substances.
Substance Type
Bromo Empagliflozin
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
[C@H]1([C@H]([C@@H]([C@H]([C@@H](O1)c2cc(c(cc2)Br)Cc3ccc(cc3)O[C@@H]4COCC4)O)O)O)CO

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Bromo Empagliflozin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

Bromo Empagliflozin

Systematic Nomenclature

(2S,3R,4R,5S,6R)-2-[4-bromo-3-[[4-[(3S)-oxolan-3-yl]oxyphenyl]methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol
2-[4-bromo-3-[[4-[(3S)-oxolan-3-yl]oxyphenyl]methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol, (2S,3R,4R,5S,6R)-